NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Vaccines |  News | 0 Comment | 15 Nov, 2019

Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, announced that the com...Read more

Takeda’s Dengue vaccine candidate reveals protection in children

Vaccines |  News | 0 Comment | 08 Nov, 2019

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of the ongoing pivotal Phase 3 Tetravalent Immunization against Den...Read more

FDA approves Sanofi’s Influenza Vaccine for older people

Vaccines |  News | 0 Comment | 05 Nov, 2019

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 y...Read more

The Union reports efficacy of its TB Vaccine Candidate

Vaccines |  News | 0 Comment | 30 Oct, 2019

International Union Against Tuberculosis and Lung Disease (The Union) headquartered in France, announces the Phase IIb Trial results of its Tuberculosis Vaccine Candidate GSK/IAVI M72. ...Read more

NIH awards contracts to advance tuberculosis immunology research

Vaccines |  News | 0 Comment | 27 Sep, 2019

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immu...Read more

Alwaleed Philanthropies invests $5 M in global fight for vaccines

Vaccines |  News | 0 Comment | 02 Sep, 2019

Alwaleed Philanthropies, chaired by HRH Prince Alwaleed Bin Talal Bin Abdulaziz AlSaud, the global philanthropic foundation, has made a fresh commitment to preventing the spread of dis...Read more

Crozet partners with PHV to develop Nipah virus vaccine

Vaccines |  News | 0 Comment | 28 Aug, 2019

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (PHV), to advance the development and manufacture of a vaccine against ...Read more

Zuellig Pharma, NICVB, NIHE team up for accessibility of vaccines

Vaccines |  News | 0 Comment | 23 Apr, 2019

The National Institute of Vaccines and Medical Biologicals (NICVB), the National Institute of Hygiene and Epidemiology (NIHE) and Zuellig Pharma have officially announced a project to expan...Read more

The Govt. of EG, US Energy Companies & Sanaria collaborate for malaria vaccine

Vaccines |  News | 0 Comment | 11 Apr, 2019

Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint commitment to develop Sanaria® PfSPZ Vaccine as a tool for malari...Read more

Serum Institute launches biggest immunisation awareness drive in India

Vaccines |  News | 0 Comment | 22 Feb, 2019

Serum Institute of India (SII), vaccine manufacturer launched a nation-wide vaccination and immunisation campaign called ‘Swasth Immunised India’ in association with Network18, ...Read more

Vertex announces EC approval for ORKAMBI

Vaccines |  News | 0 Comment | 24 Jan, 2019

Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatm...Read more

Exelixis announces USFDA approval of CABOMETYX

Vaccines |  News | 0 Comment | 16 Jan, 2019

Oncology focused biotechnology company, Exelixis has announced that USFDA has approved CABOMETYX tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated wi...Read more

AstraZeneca’s Bevespi Aerosphere approved in the EU

Vaccines |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formoterol fumarate) in a pressurised metered-dose inhaler (pMDI) as a maint...Read more

FDA approves Sanofi & MSD’s VAXELIS™

Vaccines |  News | 0 Comment | 03 Jan, 2019

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningoc...Read more

Philip Gutry appointed as Chief Business Officer by Kronos Bio

Vaccines |  News | 0 Comment | 28 Nov, 2018

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly created role, Philip will drive the company’s business development...Read more

Esco, Nuvonis enter into MoU to support novel vaccines in Asia

Vaccines |  News | 0 Comment | 04 Oct, 2018

Singapore - Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for the early development and manufacturing of viral vaccines prevalent i...Read more

Enesi, Public Health England carry out R&D collaboration

Vaccines |  News | 0 Comment | 03 Oct, 2018

Singapore - Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dosevaccine products, announces it has entered a researc...Read more

GSK TB vaccine shows promise in phII study

Vaccines |  News | 0 Comment | 30 Sep, 2018

Pharma giant GSK and Aeras reported that GSK’s candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults with latent tuberculosis ...Read more